Globe on Big Pharma R&D Failure
3 Comments
Recent Posts
Nobody Wants This: Senate Rejects Government’s Anti-Privacy Plan for Political Parties By Sending Bill Back to the House With a Sunset Clause 
The Law Bytes Podcast, Episode 258: Jaxson Khan With an Insider Perspective on AI Policy Development in Canada 
Time for the Government to Fix Its Political Party Privacy Blunder: Kill Bill C-4’s Disastrous Privacy Rules 
The Law Bytes Podcast, Episode 257: Lisa Given on What Canada Can Learn From Australia’s Youth Social Media Ban 
Court Ordered Social Media Site Blocking Coming to Canada?: Trojan Horse Online Harms Bill Clears Senate Committee Review
So, repeal C-22
If the drug companies can renege, then so can the goodies that were given to them be taken away.
Seems pretty straightforward to me.
Why aren’t there such things as charitable venture capital orgs? After-all many charities (eg JDRC) contribute to for-profit orgs. It seems to me that charitable donations would go much further if the beneficiaries of donations (R&D orgs) had to contribute returns back to charities. The role of charities like JDRC then would be to encourage R&D firms to take greater risks.
Hey, Michael! Don’t be so ungrateful or narrow minded. What about the bevy of busy lawyers who make gazillions every year doing “research” on their endless litany of pharmaceutical patent cases in the courts? What about all that useful literature and education directed at the medical profession, so that they are better informed about what pills their patients should pop? That takes a lot of “research and development”. And what about all the consumer focus group “research†that goes into those cute Cialis TV commercials?